SYSTEMIC THERAPY IN PANCREATIC CANCER: FROM CYTOTOXIC REGIMENS TO MOLECULARLY TARGETED TREATMENT
Keywords:
Keywords: pancreatic cancer, chemotherapy, FOLFIRINOX, KRAS, PARP inhibitors, precision oncologyAbstract
Most patients with pancreatic cancer present with locally advanced or metastatic disease, making systemic therapy the cornerstone of treatment. Despite incremental progress, durable responses remain uncommon, and the tumor's dense stroma and immunosuppressive microenvironment contribute to treatment resistance.
Downloads
Published
2026-10-20
Issue
Section
Articles